Sample size used to validate a scale: A review of publications on newly-developed patient reported outcomes measures

Health and Quality of Life Outcomes

Volumn 12, Issue 1, 2014, Pages

  Anthoine, Emmanuelle ^a,b   Moret, Lela ^a,b   Regnault, Antoine ^b,c   Sbille, Vronique ^a,b   Hardouin, Jean Benoit ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Universite de Nantes   (France)

^c HEOR and Strategic Market Access   (France)

Author keywords

Health status; Psychometrics; Review; Sample size; Scale; Validation

Indexed keywords

CLINICAL PRACTICE; CONSTRUCT VALIDITY; CONTENT VALIDITY; CRITERION RELATED VALIDITY; DATA EXTRACTION; HUMAN; INTERNAL CONSISTENCY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT REPORTED OUTCOME; PROXY PATIENT REPORTED OUTCOME; PSYCHOMETRY; PUBLICATION; QUANTITATIVE STUDY; RATING SCALE; REVIEW; SAMPLE SIZE; SELF REPORT; SYSTEMATIC REVIEW; VALIDATION STUDY; CROSS-SECTIONAL STUDY; QUALITY OF LIFE; REPRODUCIBILITY;

CROSS-SECTIONAL STUDIES; HUMANS; PATIENT OUTCOME ASSESSMENT; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; VALIDATION STUDIES AS TOPIC;

EID: 84964315884     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-014-0176-2     Document Type: Review

References (39)

1. US Food and Drug Administration: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Guidance for Industry. 2009. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
2. Fayers PM, Machin D: Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes. 2nd edition. West Sussex, England: John Wiley & Sons Ltd; 2007.
3. Moher D, Schulz KF, Altman D: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001, 285:1987-1991.
4. Von Elm E, Altman DG, Egger M, Pocock SJ, Gtzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008, 61:344-349.
5. Des Jarlais DC, Lyles C, Crepaz N: Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004, 94:361-366.
6. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HCW, Lijmer JG: The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003, 138:W1-W12.
7. Little J, Higgins JPT, Ioannidis JPA, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N: Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol 2009, 24:37-55.
8. Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD: Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 2013, 309:814-822.
9. Scientific Advisory Committee of the Medical Outcomes Trust: Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002, 11:193-205.
10. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, Rothman M: Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000, 9:887-900.
11. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HCW: The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010, 19:539-549.
12. Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD, Lyons JC, Lenderking WR, Hinds PS, Hays RD, Greenhalgh J, Gershon R, Feeny D, Fayers PM, Cella D, Brundage M, Ahmed S, Aaronson NK, Butt Z: ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res 2013, 22:1889-1905.
13. Coste J, Fermanian J, Venot A: Methodological and statistical problems in the construction of composite measurement scales: a survey of six medical and epidemiological journals. Stat Med 1995, 14:331-345.
14. Tacconelli E: Systematic reviews: CRD's guidance for undertaking reviews in health care. Lancet Infect Dis 2010, 10:226.
15. Mokkink LB, Terwee CB, Stratford PW, Alonso J, Patrick DL, Riphagen I, Knol DL, Bouter LM, de Vet HCW: Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Qual Life Res 2009, 18:313-333.
16. Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, Bouter LM, de Vet HC: The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 2010, 10:22.
17. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HCW: The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010, 63:737-745.
18. Cicchetti DV, Feinstein AR: High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol 1990, 43:551-558.
19. De Boer MR, Moll AC, de Vet HCW, Terwee CB, Vlker-Dieben HJM, van Rens GHMB: Psychometric properties of vision-related quality of life questionnaires: a systematic review. Ophthalmic Physiol Opt 2004, 24:257-273.
20. Schellingerhout JM, Verhagen AP, Heymans MW, Koes BW, de Vet HC, Terwee CB: Measurement properties of disease-specific questionnaires in patients with neck pain: a systematic review. Qual Life Res 2012, 21:659-670.
21. Chassany O, Holtmann G, Malagelada J, Gebauer U, Doerfler H, Devault K: Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2008, 27:1053-1070.
22. Martinez-Martin P, Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, Selai C, Siderowf A, Welsh M, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG, Schrag A: Health-related quality-of-life scales in Parkinsons disease: critique and recommendations. Mov Disord 2011, 26:2371-2380.
23. Adair B, Said CM, Rodda J, Morris ME: Psychometric properties of functional mobility tools in hereditary spastic paraplegia and other childhood neurological conditions. Dev Med Child Neurol 2012, 54:596-605.
24. Bowling A: The Psychometric Properties of the Older People's Quality of Life Questionnaire, Compared with the CASP-19 and the WHOQOL-OLD. Curr Gerontol Geriatr Res 2009, 2009:12.
25. Deal LS, Williams VSL, DiBenedetti DB, Fehnel SE: Development and psychometric evaluation of the endometriosis treatment satisfaction questionnaire. Qual Life Res 2010, 19:899-905.
26. MacCallum RC, Widaman KF, Zhang S, Hong S: Sample size in factor analysis. Psychol Methods 1999, 4:84-99.
27. Hair JE, Anderson RE, Tatham RL, Black WC: Multivariate Data Analysis: With Readings, Volume 1995. Englewood Cliffs, NJ: Prentice-Hall; 1995:757.
28. Kline P: Psychometrics and Psychology, Volume 1979. London: Academic Press; 1979:381.
29. Everitt BS: Multivariate analysis: the need for data, and other problems. Br J Psychiatry 1975, 126:237-240.
30. Gorsuch RL: Factor Analysis. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates; 1983:448.
31. Cattell RB: The Scientific Use of Factor Analysis in Behavioral and Life Sciences. New-York: Springer; 1978:618.
32. Comrey AL, Lee HB: A First Course in Factor Analysis. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates; 1992:488.
33. Schumacker RE, Lomax RG: A Beginner's Guide to Structural Equation Modeling: Second Edition. New-York: Routledge Academic; 2004:498.
34. Boomsma A, Hoogland JJ: The Robustness of LISREL Modeling Revisited. In Structural Equation Modeling: Present and Future. R Cudeck; 2001:139-168.
35. Hoogland JJ, Boomsma A: Robustness studies in covariance structure modeling: an overview and a meta-analysis. Sociol Methods Res 1998, 26:329-367.
36. Muthen LK, Muthen BO: How to use a Monte Carlo study to decide on sample size and determine power. Struct Equ Model 2002, 9:599-620.
37. MacCallum RC, Browne MW, Sugawara HM: Power analysis and determination of sample size for covariance structure modeling. Psychol Methods 1996, 1:130-149.
38. Lai K, Kelley K: Accuracy in parameter estimation for targeted effects in structural equation modeling: sample size planning for narrow confidence intervals. Psychol Methods 2011, 16:127-148.
39. Lomas J, Pickard L, Mohide A: Patient versus clinician item generation for quality-of-life measures. The case of language-disabled adults. Med Care 1987, 25:764-769.